GLUE

NASDAQStock

Monte Rosa Therapeutics, Inc.

$16.03-0.01 (-0.06%)

52-Week Range

$3.70
$25.31

Key Stats

Market Cap

1.0B

P/E Ratio

Dividend Yield

Beta

1.64

Volume

596.5K

Avg Volume

956.9K

Performance

1M

-10.49%

3M

-2.49%

6M

+147.91%

YTD

+4.77%

1Y

+138.34%

3Y

+128.82%

5Y

-24.27%

Price Chart

ETF Exposure

GLUE is held by 93 ETFs

ETFFund NameWeight
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.01%
CUS1.LiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
CUSS.LiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
SXRG.DEiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
IUSN.DEiShares MSCI World Small Cap UCITS ETF0.01%
SMMDiShares Russell 2500 ETF0.01%
WSML.LiShares MSCI World Small Cap UCITS ETF0.01%
WSMLiShares MSCI World Small-Cap ETF0.01%
HDGProShares - Hedge Replication ETF0.00%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
USFM.LUBS MSCI USA Select Factor Mix UCITS ETF USD dis0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
AVUQAvantis U.S. Quality ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 2

About GLUE ETF Exposure

Monte Rosa Therapeutics, Inc. (GLUE) is held by 93 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.0B, GLUE is a widely held institutional stock. The stock currently trades at $16.03. Investors can gain exposure to GLUE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold GLUE, sorted by portfolio weight.